July 14, 2016
Contact
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
(410) 706-5260
Related stories
Thursday, March 09, 2023
Leading Physician-Scientist Dr. William F. Regine Named Senior Associate Dean for Clinical Affairs at UM School of Medicine and President of UM Faculty Physicians, Inc.
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD announced today that William F. Regine, MD, FACR, FASTRO, FACRO has been appointed to the executive role of Senior Associate Dean for Clinical Affairs at the University of Maryland School of Medicine (SOM), effective immediately.
Tuesday, November 17, 2020
UMSOM's Department of Radiation Oncology Announces New Endowed Professorship and Senior Leadership Appointments in the Department
University of Maryland School of Medicine (UMSOM) Department of Radiation Oncology Chair William F. Regine, MD, FACR, FACRO, along with UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced today that three prominent faculty members in the Department of Radiation Oncology will be promoted into leading department positions that recognize their outstanding academic scholarship and success.
Monday, September 24, 2018
University of Maryland School of Medicine Researchers to Present Original Research at Key Radiation Conference
The University of Maryland School of Medicine (UMSOM) announced that the Division of Translational Radiation Science (DTRS) will participate in the annual meeting of the Radiation Research Society (RRS) on September 23-26, 2018, in Chicago.
Friday, December 22, 2017
First Stereotactic Radiation Therapy System Designed To Treat Early Stage Breast Cancer Receives FDA Clearance
The GammaPod ™ – a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer – has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.
Thursday, August 10, 2017
Study Finds That Proton-Beam Therapy is Safe for Treating an Aggressive Type of Lung Cancer
Proton-beam radiotherapy is safe and appears to be effective in treating some cases of small cell lung cancer (SCLC), an aggressive cancer that accounts for about 10 to 15 percent of all lung cancers, according to a new study published online in the journal Cancer.
Thursday, October 27, 2016
Dr. William F. Regine is Awarded 2016 Entrepreneur of the Year From the University of Maryland, Baltimore
William F. Regine, MD, FACR, FACRO, the Isadore & Fannie Schneider Foxman Endowed Chair and Professor in Radiation Oncology at the University of Maryland School of Medicine (UM SOM) and Executive Director of the Maryland Proton Treatment Center (MPTC) has been awarded the 2016 Entrepreneur of the Year from the University of Maryland, Baltimore (UMB).
Friday, January 15, 2016
UM SOM to Participate in Expanded Medical Countermeasures Research Project
University of Maryland School of Medicine (UM SOM) Department of Radiation Oncology Chair and Professor William F. Regine, MD, FACR, FACRO, and UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that researchers at the UM SOM have been selected as key contractors by the Biomedical Advanced Research and Development Authority (BARDA), for its Radiation Nuclear Animal Model Development program. BARDA is part of the Office of the Secretary for Preparedness and Response in the U.S. Department of Health and Human Services (DHHS).